DK0546007T3 - Produkt, og anvendelse heraf til behandling af kataboliske tilstande, omfattende autentisk IGF-1 og hypokaloriske mængder af næringsmidler - Google Patents

Produkt, og anvendelse heraf til behandling af kataboliske tilstande, omfattende autentisk IGF-1 og hypokaloriske mængder af næringsmidler

Info

Publication number
DK0546007T3
DK0546007T3 DK91915377.5T DK91915377T DK0546007T3 DK 0546007 T3 DK0546007 T3 DK 0546007T3 DK 91915377 T DK91915377 T DK 91915377T DK 0546007 T3 DK0546007 T3 DK 0546007T3
Authority
DK
Denmark
Prior art keywords
hypocaloric
amounts
treatment
food
product
Prior art date
Application number
DK91915377.5T
Other languages
English (en)
Inventor
Linda Fryklund
Peter Gluckman
Anna Skottner
Original Assignee
Pharmacia & Upjohn Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=20380208&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK0546007(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Pharmacia & Upjohn Ab filed Critical Pharmacia & Upjohn Ab
Application granted granted Critical
Publication of DK0546007T3 publication Critical patent/DK0546007T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/30—Insulin-like growth factors, i.e. somatomedins, e.g. IGF-1, IGF-2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Endocrinology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
DK91915377.5T 1990-08-24 1991-08-22 Produkt, og anvendelse heraf til behandling af kataboliske tilstande, omfattende autentisk IGF-1 og hypokaloriske mængder af næringsmidler DK0546007T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9002731A SE9002731D0 (sv) 1990-08-24 1990-08-24 Product comprising growth factor

Publications (1)

Publication Number Publication Date
DK0546007T3 true DK0546007T3 (da) 1997-03-17

Family

ID=20380208

Family Applications (1)

Application Number Title Priority Date Filing Date
DK91915377.5T DK0546007T3 (da) 1990-08-24 1991-08-22 Produkt, og anvendelse heraf til behandling af kataboliske tilstande, omfattende autentisk IGF-1 og hypokaloriske mængder af næringsmidler

Country Status (14)

Country Link
US (1) US6034059A (da)
EP (1) EP0546007B2 (da)
JP (1) JP2521867B2 (da)
AT (1) ATE147988T1 (da)
AU (1) AU650050B2 (da)
CA (1) CA2088674A1 (da)
DE (1) DE69124382T3 (da)
DK (1) DK0546007T3 (da)
ES (1) ES2097816T5 (da)
GR (1) GR3022935T3 (da)
IE (1) IE912615A1 (da)
PT (1) PT98764B (da)
SE (1) SE9002731D0 (da)
WO (1) WO1992003154A1 (da)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9402331D0 (sv) * 1994-07-01 1994-07-01 Pharmacia Ab New use
US6335317B1 (en) 1998-04-10 2002-01-01 Emory University Use of gut-trophic growth factors to improve oxidative status
AU2002239560B2 (en) * 2000-11-28 2006-03-02 Premacure Ab Determination of risk and treatment of complications of prematurity
JP3896879B2 (ja) * 2002-03-22 2007-03-22 日本電気株式会社 トラヒック監視システム
WO2006130769A2 (en) 2005-06-02 2006-12-07 Tercica, Inc. Methods for treatment of growth disorders

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE81779T1 (de) * 1985-08-22 1992-11-15 Gropep Pty Ltd Peptidanalogedes insulinaehnlichen wachstumsfaktors-1 bei saeugetieren.
US4963665A (en) * 1986-01-07 1990-10-16 Washington University Human preproinsulin-like growth factor I
EP0288478B1 (en) * 1986-01-09 1992-08-19 Brigham And Women's Hospital Use of growth hormone for nitrogen retention under hypocaloric conditions
ATE82506T1 (de) * 1987-08-21 1992-12-15 Imcera Group Inc Stabilisierung von wachstumshormonen.
JP2507106B2 (ja) * 1987-12-24 1996-06-12 グロペップ プロプライエタリー リミテッド インスリン様成長因子１（ｉｇｆ―１）または因子２（ｉｇｆ―２）の類縁ペプチド

Also Published As

Publication number Publication date
PT98764B (pt) 1999-01-29
ES2097816T5 (es) 2003-07-16
US6034059A (en) 2000-03-07
EP0546007B1 (en) 1997-01-22
PT98764A (pt) 1993-09-30
IE912615A1 (en) 1992-02-26
GR3022935T3 (en) 1997-06-30
AU650050B2 (en) 1994-06-09
WO1992003154A1 (en) 1992-03-05
DE69124382T3 (de) 2003-09-11
EP0546007A1 (en) 1993-06-16
AU8448891A (en) 1992-03-17
DE69124382T2 (de) 1997-06-26
JP2521867B2 (ja) 1996-08-07
CA2088674A1 (en) 1992-02-25
SE9002731D0 (sv) 1990-08-24
DE69124382D1 (de) 1997-03-06
EP0546007B2 (en) 2003-01-29
JPH05509323A (ja) 1993-12-22
ES2097816T3 (es) 1997-04-16
ATE147988T1 (de) 1997-02-15

Similar Documents

Publication Publication Date Title
ATE139447T1 (de) Mittel zur verstaerkung der wirkung von antitumoralen mittel und zur widerstandsbekaempfung von vielfachdrogen
FI950369A0 (fi) Hedelmöitettyjä kuorellisia munia käsittävä koostumus
SE9401406D0 (sv) Pharmaceutical products for curing tumourous diseases and process for preparing same
ATE185548T1 (de) Verwendung von n-arylmethylen ethylendiamintriacetate, n-arylmethylen iminodiacetat oder n,n'-diarylmethylen ethylendiamindiacetat gegen oxidativen stress
ATE126972T1 (de) Formulierung zur behandlung von silage.
CY2495B1 (en) Sulfonamides.
DK0830377T3 (da) Glucagon-lignende peptid-2 og dets terapeutiske anvendelse
DE69526937D1 (de) Verwendung von methanbisphosphonsäurederivaten zur behandlung von aufgelockerten prothesen
GR3032037T3 (en) Immunogen compounds having specifically an anti-cytokine effect, method of preparation, pharmaceutical compositions and kits containing them
ATE128870T1 (de) Zusammensetzungen zur behandlung von fettablagerungen.
NO965094L (no) [aÅ-annelerte pyrrolderivater og anvendelse av disse i farmasien
ATE260117T1 (de) Pharmazeutische zusammensetzung zur behandlung von parkinsonkrankheit oder depression
DK0589995T3 (da) Hidtil ukendte polypeptider og deres anvendelse
ATE289808T1 (de) Caroteinoid-nicotinamid-zink zusammensetzungen und verfahren zur behandlung unter verwendung derselben
DK0561846T3 (da) 4,5-dihydroxy- og 4,5,8-trihydroxy-9,10-dihydro-9,10-dioxo-2-anthracencarboxylsyre-dicarbonater og -urethaner med terapeutisk virkning
YU42298A (sh) Upotreba olanzapina za pripremanje leka korisnog kod akutnog bola
TW261532B (da)
SE9002731D0 (sv) Product comprising growth factor
ATE64300T1 (de) Wirkstoffe zur anwendung bei der behandlung von tumoren.
DE69427116D1 (de) Verwendung von 4'-iodo - 4 - deoxydoxorubicin zur behandlung von amyloidosis
DE69734349D1 (de) Behandlung von knochenleiden mit adrenomedullin
GB9024927D0 (en) Novel treatment
NO960866D0 (no) Fremgangsmåte til behandling av leversykdom og lignende indikasjoner med vasodilaterende midler
DE69319140D1 (de) 4-guanidinobutyramid zur verbesserung des blutkreislaufs
DK105791D0 (da) Broed-erstattende fiberholdigt produkt med blodsukker saenkende og insulin besparende virkning. udelukkende tillavet af naturlige foedevare-ingredienser